Attached files
| file | filename |
|---|---|
| EX-31 - EXHIBIT 31.2 - Teligent, Inc. | ex312_74395.htm |
| EX-31 - EXHIBIT 31.1 - Teligent, Inc. | ex311_74395.htm |
| EX-32 - EXHIBIT 32.1 - Teligent, Inc. | ex321_74395.htm |
| EX-10 - EXHIBIT 10.4 - Teligent, Inc. | ex104_74395.htm |
| EX-10 - EXHIBIT 10.3 - Teligent, Inc. | ex103_74395.htm |
| 10-Q - BODY OF FORM 10-Q - Teligent, Inc. | d74395_igi10q.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of IGI Laboratories, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Philip S. Forte, Chief Financial Officer of the Company, state and certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 17, 2010
| /s/ Philip S. Forte |
| Philip S. Forte |